Optimization and evaluation of electroporation delivery of siRNA in the human leukemic CEM cell line

Cytotechnology

Volumn 62, Issue 6, 2010, Pages 497-507

  Fyrberg, Anna ^a   Lotfi, Kourosh ^a,b  

^a LINKÖPING UNIVERSITY   (Sweden)

^b LINKÖPING UNIVERSITY HOSPITAL   (Sweden)

Author keywords

Deoxycytidine kinase; Electroporation; Microarray; Nucleoside analog; RNAi

Indexed keywords

DEOXYCYTIDINE KINASE; DNA; LIPID; MESSENGER RNA; NUCLEOSIDE ANALOG; SMALL INTERFERING RNA;

ARTICLE; CELL STRAIN CEM; CONTROLLED STUDY; CULTURE MEDIUM; CYTOSOL; DESMOSOME; DNA REPAIR; DOWN REGULATION; ELECTROPORATION; ENZYME ACTIVITY; GENE EXPRESSION; GENETIC TRANSFECTION; HUMAN; HUMAN CELL; HUMAN CELL CULTURE; LEUKEMIA CELL LINE; MICROARRAY ANALYSIS; TEMPERATURE;

EID: 78651493211     PISSN: 09209069     EISSN: 15730778     Source Type: Journal    
DOI: 10.1007/s10616-010-9309-6     Document Type: Article

References (27)

1. ES Arner S Eriksson 1995 Mammalian deoxyribonucleoside kinases Pharmacol Ther 67 155 186 1:CAS:528:DyaK2MXotVGhtb8%3D 10.1016/0163-7258(95)00015-9
2. AB Bahnson SS Boggs 1990 Addition of serum to electroporated cells enhances survival and transfection efficiency Biochem Biophys Res Commun 171 752 757 1:CAS:528:DyaK3cXmtVKitbc%3D 10.1016/0006-291X(90)91210-J
3. L Bai M Yamaguchi M Tatsumi K Kon M Brautigam 1998 Mechanisms responsible for resistance of sublines derived from leukemia cell lines to an antitumor agent 9-beta-D-arabinofuranosyl-2-fluoroadenine J Cancer Res Clin Oncol 124 367 373 1:CAS:528:DyaK1cXmsVKkt7Y%3D 10.1007/s004320050185
4. AM Bergman PP Eijk VW van Ruiz Haperen K Smid G Veerman I Hubeek P van den Ijssel B Ylstra GJ Peters 2005 In vivo induction of resistance to gemcitabine results in increased expression of ribonucleotide reductase subunit M1 as the major determinant Cancer Res 65 9510 9516 1:CAS:528:DC%2BD2MXhtFWmu7rJ 10.1158/0008-5472.CAN-05-0989
5. E Ferret C Evrard A Foucal P Gervais 2000 Volume changes of isolated human K562 leukemia cells induced by electric field pulses Biotechnol Bioeng 67 520 528 1:CAS:528:DC%2BD3cXhtFKjur4%3D 10.1002/(SICI)1097-0290(20000305)67: 5<520::AID-BIT3>3.0.CO;2-J
6. M Fox JM Boyle AR Kinsella 1991 Nucleoside salvage and resistance to antimetabolite anticancer agents Br J Cancer 64 428 436 1:CAS:528: DyaK38XisA%3D%3D
7. A Fyrberg F Albertioni K Lotfi 2007 Cell cycle effect on the activity of deoxynucleoside analogue metabolising enzymes Biochem Biophys Res Commun 357 847 853 1:CAS:528:DC%2BD2sXlt1ajsrw%3D 10.1016/j.bbrc.2007.03.176
8. YG Goan B Zhou E Hu S Mi Y Yen 1999 Overexpression of ribonucleotide reductase as a mechanism of resistance to 2, 2-difluorodeoxycytidine in the human KB cancer cell line Cancer Res 59 4204 4207 1:CAS:528:DyaK1MXlvVSnu7o%3D
9. O Guittet P Hakansson N Voevodskaya S Fridd A Graslund H Arakawa Y Nakamura L Thelander 2001 Mammalian p53R2 protein forms an active ribonucleotide reductase in vitro with the R1 protein, which is expressed both in resting cells in response to DNA damage and in proliferating cells J Biol Chem 276 40647 40651 1:CAS:528:DC%2BD3MXosVKhtLY%3D 10.1074/jbc.M106088200
10. RA Irizarry B Hobbs F Collin YD Beazer-Barclay KJ Antonellis U Scherf TP Speed 2003 Exploration, normalization, and summaries of high density oligonucleotide array probe level data Biostatistics 4 249 264 10.1093/biostatistics/4.2.249
11. D Lembo G Gribaudo A Hofer L Riera M Cornaglia A Mondo A Angeretti M Gariglio L Thelander S Landolfo 2000 Expression of an altered ribonucleotide reductase activity associated with the replication of murine cytomegalovirus in quiescent fibroblasts J Virol 74 11557 11565 1:CAS:528:DC%2BD3MXitVGju78%3D 10.1128/JVI.74.24.11557-11565.2000
12. Y Liu R Bergan 2001 Improved intracellular delivery of oligonucleotides by square wave electroporation Antisense Nucleic Acid Drug Dev 11 7 14 1:CAS:528:DC%2BD3MXhvVenurc%3D 10.1089/108729001750072083
13. K Lotfi E Mansson T Spasokoukotskaja B Pettersson J Liliemark C Peterson S Eriksson F Albertioni 1999 Biochemical pharmacology and resistance to 2-chloro-2′-arabino-fluoro-2′-deoxyadenosine, a novel analogue of cladribine in human leukemic cells Clin Cancer Res 5 2438 2444 1:CAS:528:DyaK1MXmsFyjsL8%3D
14. K Lotfi E Mansson C Peterson S Eriksson F Albertioni 2002 Low level of mitochondrial deoxyguanosine kinase is the dominant factor in acquired resistance to 9-beta-D-arabinofuranosylguanine cytotoxicity Biochem Biophys Res Commun 293 1489 1496 1:CAS:528:DC%2BD38Xks1GgsbY%3D 10.1016/S0006-291X(02)00415- 1
15. OH Lowry NJ Rosebrough AL Farr RJ Randall 1951 Protein measurement with the Folin phenol reagent J Biol Chem 193 265 275 1:CAS:528:DyaG38XhsVyrsw%3D%3D
16. E Mansson E Flordal J Liliemark T Spasokoukotskaja H Elford S Lagercrantz S Eriksson F Albertioni 2003 Down-regulation of deoxycytidine kinase in human leukemic cell lines resistant to cladribine and clofarabine and increased ribonucleotide reductase activity contributes to fludarabine resistance Biochem Pharmacol 65 237 247 1:CAS:528:DC%2BD38Xpslamtbc%3D 10.1016/S0006-2952(02)01484- 3
17. WS Meaking J Edgerton CW Wharton RA Meldrum 1995 Electroporation-induced damage in mammalian cell DNA Biochim Biophys Acta 1264 357 362
18. RA Meldrum WS Meaking CW Wharton 1994 The kinetics and mechanism of repair of UV induced DNA damage in mammalian cells. The use of 'caged' nucleotides and electroporation to study short time course events in DNA repair Nucleic Acids Res 22 1234 1241 1:CAS:528:DyaK2cXksFWhtLw%3D 10.1093/nar/22.7. 1234
19. H Melkonyan C Sorg M Klempt 1996 Electroporation efficiency in mammalian cells is increased by dimethyl sulfoxide (DMSO) Nucleic Acids Res 24 4356 4357 1:CAS:528:DyaK28XntF2nt7s%3D 10.1093/nar/24.21.4356
20. T Mosmann 1983 Rapid colorimetric assay for cellular growth and survival: application to proliferation and cytotoxicity assays J Immunol Methods 65 55 63 1:STN:280:DyaL2c%2FovFSmtw%3D%3D 10.1016/0022-1759(83)90303-4
21. P Nordlund P Reichard 2006 Ribonucleotide reductases Annu Rev Biochem 75 681 706 1:CAS:528:DC%2BD28XosVKhsLs%3D 10.1146/annurev.biochem.75.103004.142443
22. Plunkett W, Grindey GB (1987) Pharmacokinetics of the 5′-triphosphates of arabinosylcytosine and 2′,2′- difluorodeoxycytidine in L1210 cells. Nucleic Acids Symp Ser 77-79
23. NK Verma CS Dey 2004 RNA-mediated gene silencing: mechanisms and its therapeutic applications J Clin Pharm Ther 29 395 404 1:CAS:528: DC%2BD2cXhtVent77I 10.1111/j.1365-2710.2004.00579.x
24. X Wang A Zhenchuk KG Wiman F Albertioni 2009 Regulation of p53R2 and its role as potential target for cancer therapy Cancer Lett 276 1 7 1:CAS:528:DC%2BD1MXit1Ojsrk%3D 10.1016/j.canlet.2008.07.019
25. KC Xie W Plunkett 1996 Deoxynucleotide pool depletion and sustained inhibition of ribonucleotide reductase and DNA synthesis after treatment of human lymphoblastoid cells with 2-chloro-9-(2-deoxy-2-fluoro-beta-D- arabinofuranosyl) adenine Cancer Res 56 3030 3037 1:CAS:528:DyaK28XjvFCkt78%3D
26. ZW Yu PJ Quinn 1994 Dimethyl sulphoxide: a review of its applications in cell biology Biosci Rep 14 259 281 1:CAS:528:DyaK2MXlsVSktb0%3D 10.1007/BF01199051
27. C Zhu M Johansson A Karlsson 2000 Differential incorporation of 1-beta-D-arabinofuranosylcytosine and 9-beta-D-arabinofuranosylguanine into nuclear and mitochondrial DNA FEBS Lett 474 129 132 1:CAS:528: DC%2BD3cXjs1Chtrw%3D 10.1016/S0014-5793(00)01569-6